Literature DB >> 32754788

Barriers and facilitators to CDH1 carriers contemplating or undergoing prophylactic total gastrectomy.

Kaitlin M McGarragle1, Tae L Hart2,3, Carol Swallow1,4,5, Savtaj Brar1,5,6, Anand Govindarajan1,5,6, Zane Cohen1,5,6, Melyssa Aronson1,7.   

Abstract

Hereditary diffuse gastric cancer (HDGC) is an inherited cancer syndrome associated with high lifetime risk of diffuse-type gastric cancer. Current guidelines recommend individuals with HDGC undergo prophylactic total gastrectomy (PTG) to eliminate this risk. However, PTG is associated with significant lifestyle changes, post-surgical recovery, and symptom burden. This study examined factors related to decision-making about PTG in three groups of individuals who: (1) underwent PTG immediately after receiving genetic testing results; (2) delayed PTG by ≥ 1 year or; (3) declined PTG. Participants were recruited from a familial gastric cancer registry at a tertiary care hospital. Patients with CDH1 pathogenic or likely pathogenic variants who contemplated and/or underwent PTG were eligible. 24 individuals contemplated PTG: 9 had immediate surgery (within a year), 8 delayed surgery, and 7 declined surgery. Data on PTG barriers and facilitators were obtained on all participants using quantitative surveys (n = 7), qualitative interviews (n = 8) or both methods (n = 9). PTG barriers included age, positive beliefs about screening, close relatives with negative PTG experiences, fertility-related concerns, and life stress. Facilitators included social support, trust in healthcare providers, understanding risk, negative beliefs about screening, family-related factors, positive or abnormal screening results, and positive attitude toward PTG. This study highlights factors related to the PTG decision-making process among individuals with HDGC from three distinct groups. Future research should explore educational interventions aimed at addressing surgery-related concerns and the limitations of screening, and might also consider incorporating close relatives as informational supports.

Entities:  

Keywords:  CDH1; Decision-making; Hereditary diffuse gastric cancer; Prophylactic surgery

Mesh:

Substances:

Year:  2020        PMID: 32754788     DOI: 10.1007/s10689-020-00197-y

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  18 in total

1.  Hereditary Diffuse Gastric Cancer Syndrome: CDH1 Mutations and Beyond.

Authors:  Samantha Hansford; Pardeep Kaurah; Hector Li-Chang; Michelle Woo; Janine Senz; Hugo Pinheiro; Kasmintan A Schrader; David F Schaeffer; Karey Shumansky; George Zogopoulos; Teresa Almeida Santos; Isabel Claro; Joana Carvalho; Cydney Nielsen; Sarah Padilla; Amy Lum; Aline Talhouk; Katie Baker-Lange; Sue Richardson; Ivy Lewis; Noralane M Lindor; Erin Pennell; Andree MacMillan; Bridget Fernandez; Gisella Keller; Henry Lynch; Sohrab P Shah; Parry Guilford; Steven Gallinger; Giovanni Corso; Franco Roviello; Carlos Caldas; Carla Oliveira; Paul D P Pharoah; David G Huntsman
Journal:  JAMA Oncol       Date:  2015-04       Impact factor: 31.777

2.  Looking different, feeling different: women's reactions to risk-reducing breast and ovarian surgery.

Authors:  Nina Hallowell; Brandi Baylock; Louise Heiniger; Phyllis N Butow; Deepa Patel; Bettina Meiser; Christobel Saunders; Melanie A Price
Journal:  Fam Cancer       Date:  2012-06       Impact factor: 2.375

3.  Prophylactic Total Gastrectomy: a Prospective Cohort Study of Long-Term Impact on Quality of Life.

Authors:  Jennifer Muir; Melyssa Aronson; Mary-Jane Esplen; Aaron Pollett; Carol J Swallow
Journal:  J Gastrointest Surg       Date:  2016-10-17       Impact factor: 3.452

4.  Prophylactic total gastrectomy (PTG) for hereditary diffuse gastric cancer (HDGC): the Newfoundland experience with 23 patients.

Authors:  P C Hebbard; A Macmillan; D Huntsman; P Kaurah; F Carneiro; X Wen; A Kwan; D Boone; F Bursey; J Green; B Fernandez; D Fontaine; D A Wirtzfeld
Journal:  Ann Surg Oncol       Date:  2009-05-01       Impact factor: 5.344

5.  Outcomes after prophylactic gastrectomy for hereditary diffuse gastric cancer.

Authors:  R T van der Kaaij; J P van Kessel; J M van Dieren; P Snaebjornsson; O Balagué; F van Coevorden; L E van der Kolk; K Sikorska; A Cats; J W van Sandick
Journal:  Br J Surg       Date:  2018-01       Impact factor: 6.939

6.  Optimal Timing of Total Gastrectomy to Prevent Diffuse Gastric Cancer in Individuals With Pathogenic Variants in CDH1.

Authors:  Monika Laszkowska; Elisabeth R Silver; Beth Schrope; Fay Kastrinos; Timothy C Wang; Chin Hur
Journal:  Clin Gastroenterol Hepatol       Date:  2019-06-18       Impact factor: 11.382

7.  Decisions about prophylactic gynecologic surgery: a qualitative study of the experience of female Lynch syndrome mutation carriers.

Authors:  Holly Etchegary; Elizabeth Dicks; Kathy Watkins; Sabrina Alani; Lesa Dawson
Journal:  Hered Cancer Clin Pract       Date:  2015-03-19       Impact factor: 2.857

Review 8.  Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers.

Authors:  Rachel S van der Post; Ingrid P Vogelaar; Fátima Carneiro; Parry Guilford; David Huntsman; Nicoline Hoogerbrugge; Carlos Caldas; Karen E Chelcun Schreiber; Richard H Hardwick; Margreet G E M Ausems; Linda Bardram; Patrick R Benusiglio; Tanya M Bisseling; Vanessa Blair; Eveline Bleiker; Alex Boussioutas; Annemieke Cats; Daniel Coit; Lynn DeGregorio; Joana Figueiredo; James M Ford; Esther Heijkoop; Rosella Hermens; Bostjan Humar; Pardeep Kaurah; Gisella Keller; Jennifer Lai; Marjolijn J L Ligtenberg; Maria O'Donovan; Carla Oliveira; Hugo Pinheiro; Krish Ragunath; Esther Rasenberg; Susan Richardson; Franco Roviello; Hans Schackert; Raquel Seruca; Amy Taylor; Anouk Ter Huurne; Marc Tischkowitz; Sheena Tjon A Joe; Benjamin van Dijck; Nicole C T van Grieken; Richard van Hillegersberg; Johanna W van Sandick; Rianne Vehof; J Han van Krieken; Rebecca C Fitzgerald
Journal:  J Med Genet       Date:  2015-05-15       Impact factor: 6.318

9.  Examining intrafamilial communication of colorectal cancer risk status to family members and kin responses to colonoscopy: a qualitative study.

Authors:  Kaitlin M McGarragle; Crystal Hare; Spring Holter; Dorian Anglin Facey; Kelly McShane; Steven Gallinger; Tae L Hart
Journal:  Hered Cancer Clin Pract       Date:  2019-06-26       Impact factor: 2.857

10.  The impact of prophylactic total gastrectomy on health-related quality of life: a prospective cohort study.

Authors:  Elizabeth Worster; Xinxue Liu; Susan Richardson; Richard H Hardwick; Sarah Dwerryhouse; Carlos Caldas; Rebecca C Fitzgerald
Journal:  Ann Surg       Date:  2014-07       Impact factor: 12.969

View more
  1 in total

1.  CDH1 variants leading to gastric cancer risk management decision-making experiences in emerging adults: 'I am not ready yet'.

Authors:  Yi Liu; Kathleen Calzone; Grace-Ann Fasaye; John Quillin
Journal:  J Genet Couns       Date:  2021-03-02       Impact factor: 2.717

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.